Consumption of Imipenem Correlates with β-Lactam Resistance in Pseudomonas aeruginosa
Open Access
- 1 September 2002
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (9), 2920-2925
- https://doi.org/10.1128/aac.46.9.2920-2925.2002
Abstract
It is generally assumed that the antibiotic prescription policy of a hospital has a significant impact on bacterial resistance rates; however, few studies are available to support this concept with valid statistical data. During a 3-year period from 1997 to 2000, we monitored the consumption of β-lactam and other antibiotics with known activity against Pseudomonas aeruginosa in a 600-bed community hospital. Monthly isolations of P. aeruginosa were assessed, and resistance rates were recorded. Partial correlation coefficients between consumption and resistance rates were determined, taking into account possible associations with other variables such as seasonal effects and transfers from other hospitals. A total of 30 ± 7 novel P. aeruginosa strains per month were isolated without epidemic clustering. Prescriptions of imipenem varied significantly during the study period, while prescriptions of other antipseudomonal agents were stable, with the exception of an increase in piperacillin-tazobactam prescriptions. Rates of resistance of P. aeruginosa to the antimicrobial agents used showed a time course similar to figures for imipenem consumption. Monthly rates of resistance to imipenem (partial correlation coefficient [cc], 0.63), piperacillin-tazobactam (cc, 0.57), and ceftazidime (cc, 0.56) were significantly associated with imipenem prescription rates in the same or the preceding month, while consumption of ceftazidime or piperacillin-tazobactam had no apparent association with resistance. Among the variables investigated, imipenem consumption was identified as the major factor associated with both carbapenem and β-lactam resistance in endemic P. aeruginosa . Periods of extensive imipenem use were associated with significant increases in resistance. Our data support the concept that a written antibiotic policy which balances the use of various antibiotic classes may help to avoid disturbances of a hospital's microbial sensitivity patterns.This publication has 27 references indexed in Scilit:
- Tap Water Colonization With Psmdomonas aeruginosa in a Surgical Intensive Care Unit (ICU) and Relation to Psmdomonas Infections of ICU PatientsInfection Control & Hospital Epidemiology, 2001
- EndemicPseudomonas aeruginosaInfection in a Neonatal Intensive Care UnitThe New England Journal of Medicine, 2000
- Strategies for Study of the Role of Cycling on Antimicrobial Use and ResistanceInfection Control & Hospital Epidemiology, 2000
- Epidemiology and Clinical Outcomes of Patients with Multiresistant Pseudomonas aeruginosaClinical Infectious Diseases, 1999
- Nosocomial Infections With Ceftazidime-Resistant Pseudomonas aeruginosa: Risk Factors and OutcomeInfection Control & Hospital Epidemiology, 1999
- Predominant pathogens found in the European prevalence of infection in intensive care studyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- Vergleichende Untersuchung zum Kosten-/Effektivitäts-Verhältnis einer initialen Therapie mit Imipenem/Cilastatin bei der nosokomialen PneumonieAINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie, 1996
- Emergence of vancomycin-resistant enterococci in New York CityThe Lancet, 1993
- Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1992
- Imipenem-induced resistance to antipseudomonal beta-lactams in Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1985